van der Starre P J, Trienekens P H, Harinck-de Weerd J E, Willems F T, Kootstra G J, Huige P J, Quik R F
Department of Anesthesiology, Medical Center de Klokkenberg, Breda, The Netherlands.
Ann Thorac Surg. 1988 Jan;45(1):24-7. doi: 10.1016/s0003-4975(10)62389-2.
In two groups of patients undergoing coronary artery bypass grafting (CABG), two different regimens of antibiotic prophylaxis with cefamandole nafate were compared. In Group 1, 30 mg per kilogram of body weight was administered intravenously during induction of anesthesia. In Group 2, a second dose of 15 mg/kg was administered intravenously shortly before cannulation. Serum and tissue levels in the right atrium, the pericardium, and the sternum were determined using high-pressure liquid chromatography. The results showed that in Group 2 the serum levels were significantly higher from 48 minutes onward after induction and remained at an acceptable level during CABG. The tissue levels in the sternum and pericardium were also significantly higher in Group 2 compared with Group 1. It is concluded that a second dose of cefamandole (15 mg/kg) shortly before the beginning of cardiopulmonary bypass is recommended, particularly for high-risk patients.
在两组接受冠状动脉旁路移植术(CABG)的患者中,比较了两种不同的头孢孟多酯钠抗生素预防方案。在第1组中,麻醉诱导期间静脉注射每千克体重30毫克。在第2组中,在插管前不久静脉注射第二剂15毫克/千克。使用高压液相色谱法测定右心房、心包和胸骨中的血清和组织水平。结果表明,在第2组中,诱导后48分钟起血清水平显著更高,并且在冠状动脉旁路移植术期间保持在可接受水平。与第1组相比,第2组胸骨和心包中的组织水平也显著更高。得出结论,建议在体外循环开始前不久给予第二剂头孢孟多(15毫克/千克),特别是对于高危患者。